BridgeMD
New treatment option for Suicide
Official title Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline
ClinicalTrials.gov ID: NCT07343258
What this study is testing
- What it's testing
- This pilot study aims to assess the acceptance, feasibility, and added value of follow-up calls at the suicide helpline, Zelfmoordlijn 1813, in Flanders (Belgium). It serves as a crucial preparatory step in the development and implementation process of the callback methodology at Zelfmoordlijn 1813.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Callers
- The caller is 18 years or older.
- The caller speaks Dutch.
- The caller calls the Zelfmoordlijn 1813 for themselves due to suicidal ideation.
- The caller must benefit from callback conversations fitting one of the three callback profiles.
You likely can't join if
- The caller is younger than 18 years.
- The caller does not speak Dutch.
- The caller does not call the Zelfmoordlijn 1813 for themselves.
- The caller is a frequent caller to the Zelfmoordlijn 1813.
- The call responder assesses that urgent medical help is necessary.
- The caller expresses a homocide threat during the original conversation to the Zelfmoordlijn 1813.
See the full eligibility criteria
- Callers
- The caller is 18 years or older.
- The caller speaks Dutch.
- The caller calls the Zelfmoordlijn 1813 for themselves due to suicidal ideation.
- The caller must benefit from callback conversations fitting one of the three callback profiles.
- The caller is not a frequent caller to the Zelfmoordlijn 1813.
- The caller can be called back directly on a personal device.
- The caller is legally competent, meaning they can oversee the potential consequences of participation, such as time investment and availability.
- At the time of recruitment, the caller is not receiving support within a care trajectory where attention is paid to their suicidality. Or the care provider is not available quickly enough (e.g., due to maternity leave)...
- The caller is younger than 18 years.
- The caller does not speak Dutch.
- The caller does not call the Zelfmoordlijn 1813 for themselves.
- The caller is a frequent caller to the Zelfmoordlijn 1813.
- The call responder assesses that urgent medical help is necessary.
- The caller expresses a homocide threat during the original conversation to the Zelfmoordlijn 1813.
- The caller cannot be called back on a personal device (e.g., persons in detention).
- The caller is not legally competent to oversee the consequences of participation (e.g., under the influence of alcohol and/or drugs).
- At the time of recruitment, the caller is receiving support within a care trajectory where attention is paid to their suicidality.
- Call responders The CPZ chooses to recruit call responders who have extensive experience in answering calls at the Zelfmoordlijn 1813. Therefore, not all call responders of the Zelfmoordlijn 1813 are trained to recruit...
- Callback callers The staff members of the CPZ who are involved in developing and implementing the callback methodology will also participate in the research by means of an interview.
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.